Xylem
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$5.19B N/A	$5.52B 6.29%	$7.36B 33.35%	Avg: $9.03B Low: $9.03B High: $9.03B avg. 22.63%	Avg: $9.50B Low: $9.50B High: $9.50B avg. 5.25%	Avg: $10.05B Low: $10.05B High: $10.05B avg. 5.77%
Net Income % change YoY	$427M N/A	$355M -16.86%	$609M 71.54%	Avg: $1.03B Low: $1.03B High: $1.03B avg. 70.55%	Avg: $1.16B Low: $1.16B High: $1.16B avg. 11.82%	Avg: $1.33B Low: $1.33B High: $1.33B avg. 14.77%
EBITDA % change YoY	$837M N/A	$754M -9.91%	$1.15B 52.51%	Avg: $1.42B Low: $1.42B High: $1.42B avg. 24.16%	Avg: $1.50B Low: $1.50B High: $1.50B avg. 5.25%	Avg: $1.58B Low: $1.58B High: $1.58B avg. 5.77%
EPS % change YoY	$2.37 N/A	$1.97 -16.87%	$2.81 42.63%	Avg: $4.76 Low: $4.76 High: $4.76 avg. 69.42%	Avg: $5.32 Low: $5.32 High: $5.32 avg. 11.82%	Avg: $6.11 Low: $6.11 High: $6.11 avg. 14.77%
Operating Expenses % change YoY	$1.38B N/A	$1.43B 3.61%	$2.06B 44.10%	Avg: $2.06B Low: $2.06B High: $2.06B avg. -0.05%	Avg: $2.17B Low: $2.17B High: $2.17B avg. 5.25%	Avg: $2.29B Low: $2.29B High: $2.29B avg. 5.77%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 32.38% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is 1.03B, average is 1.03B and high is 1.03B.

Wall Street analysts forecast annual average revenue growth of 11.22% in 2025-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $9.03B, average is $9.03B and high is $9.03B.

Wall Street analysts forecast annual average earnings growth of 32.00% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is $4.76, average is $4.76 and high is $4.76.